Advertisement
Screener

Catheter Precision, Inc. (VTAK) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Catheter Precision, Inc. Operating Cash Flow

Catheter Precision, Inc. (VTAK) reported Operating Cash Flow of -$5.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14

  • Catheter Precision, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.86M.
  • Catheter Precision, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.80M.
  • Catheter Precision, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.51M.
  • Catheter Precision, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.18M.
  • Catheter Precision, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$8.30M.
  • Catheter Precision, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$9.27M.
  • Catheter Precision, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$20.62M.
  • Catheter Precision, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$22.57M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2026-06-30-$2.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
-$5.66M
10-Q · filed 2026-08-14
-$7.17M
derived: sum of 3 quarters · filed 2026-08-14
-$9.35M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31-$2.80M
10-Q · filed 2026-05-18
-$4.31M
derived: sum of 2 quarters · filed 2026-05-18
-$6.49M
derived: sum of 3 quarters · filed 2026-05-18
-$8.75M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31-$1.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$3.69M
derived: sum of 2 quarters · filed 2026-03-31
-$5.96M
derived: sum of 3 quarters · filed 2026-08-14
-$8.30M
10-K · filed 2026-03-31
2025-09-30-$2.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$4.45M
derived: sum of 2 quarters · filed 2026-08-14
-$6.78M
10-Q · filed 2025-11-13
-$9.65M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$2.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
-$4.60M
10-Q · filed 2026-08-14
-$7.46M
derived: sum of 3 quarters · filed 2026-08-14
-$10.23M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31-$2.34M
10-Q · filed 2026-05-18
-$5.20M
derived: sum of 2 quarters · filed 2026-05-18
-$7.97M
derived: sum of 3 quarters · filed 2026-05-18
-$9.67M
derived: sum of 4 quarters · filed 2026-05-18
2024-12-31-$2.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$5.63M
derived: sum of 2 quarters · filed 2026-03-31
-$7.33M
derived: sum of 3 quarters · filed 2026-03-31
-$9.27M
10-K · filed 2026-03-31
2024-09-30-$2.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$4.46M
derived: sum of 2 quarters · filed 2025-11-13
-$6.41M
10-Q · filed 2025-11-13
-$8.30M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$1.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
-$3.64M
10-Q · filed 2025-08-11
-$5.53M
derived: sum of 3 quarters · filed 2025-08-11
-$7.36M
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31-$1.94M
10-Q · filed 2025-05-14
-$3.83M
derived: sum of 2 quarters · filed 2025-05-14
-$5.66M
derived: sum of 3 quarters · filed 2025-05-14
-$10.51M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31-$1.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$3.72M
derived: sum of 2 quarters · filed 2025-03-31
-$8.57M
derived: sum of 3 quarters · filed 2025-03-31
-$20.62M
10-K · filed 2025-03-31
2023-09-30-$1.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$6.68M
derived: sum of 2 quarters · filed 2024-11-14
-$18.73M
10-Q · filed 2024-11-14
-$21.75M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$4.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$16.90M
10-Q · filed 2024-08-14
-$19.93M
derived: sum of 3 quarters · filed 2024-08-14
-$24.89M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$12.05M
10-Q · filed 2024-05-06
-$15.08M
derived: sum of 2 quarters · filed 2024-05-06
-$20.04M
derived: sum of 3 quarters · filed 2024-05-06
-$26.05M
derived: sum of 4 quarters · filed 2024-05-06
2022-12-31-$3.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$7.99M
derived: sum of 2 quarters · filed 2024-04-01
-$14.00M
derived: sum of 3 quarters · filed 2024-04-01
-$22.57M
10-K · filed 2024-04-01
2022-09-30-$4.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-21
-$10.97M
derived: sum of 2 quarters · filed 2023-12-21
-$19.54M
10-Q · filed 2023-12-21
-$25.25M
derived: sum of 4 quarters · filed 2023-12-21
2022-06-30-$6.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-15
-$14.58M
10-Q · filed 2023-12-15
-$20.29M
derived: sum of 3 quarters · filed 2023-12-15
-$27.50M
derived: sum of 4 quarters · filed 2023-12-15
2022-03-31-$8.57M
10-Q · filed 2023-06-02
-$14.28M
derived: sum of 2 quarters · filed 2023-06-02
-$21.50M
derived: sum of 3 quarters · filed 2023-06-02
-$28.12M
derived: sum of 4 quarters · filed 2023-06-02
2021-12-31-$5.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
-$12.93M
derived: sum of 2 quarters · filed 2023-03-28
-$19.55M
derived: sum of 3 quarters · filed 2023-03-28
-$27.63M
10-K · filed 2023-03-28
2021-09-30-$7.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$13.84M
derived: sum of 2 quarters · filed 2022-11-14
-$21.91M
10-Q · filed 2022-11-14
-$31.33M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$6.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-16
-$14.70M
10-Q · filed 2022-08-16
-$24.11M
derived: sum of 3 quarters · filed 2022-08-16
-$30.16M
derived: sum of 4 quarters · filed 2022-08-16
2021-03-31-$8.08M
10-Q · filed 2022-05-16
-$17.49M
derived: sum of 2 quarters · filed 2022-05-16
-$23.54M
derived: sum of 3 quarters · filed 2022-05-16
-$29.34M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$9.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
-$15.46M
derived: sum of 2 quarters · filed 2022-03-24
-$21.26M
derived: sum of 3 quarters · filed 2022-03-24
-$28.30M
10-K · filed 2022-03-24
2020-09-30-$6.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
-$11.85M
derived: sum of 2 quarters · filed 2021-11-15
-$18.89M
10-Q · filed 2021-11-15
-$28.46M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$5.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
-$12.84M
10-Q · filed 2021-08-11
-$22.41M
derived: sum of 3 quarters · filed 2021-08-11
-$30.27M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31-$7.04M
10-Q · filed 2021-05-12
-$16.61M
derived: sum of 2 quarters · filed 2021-05-12
-$24.47M
derived: sum of 3 quarters · filed 2021-05-12
-$31.27M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31-$9.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17
-$17.43M
derived: sum of 2 quarters · filed 2021-03-17
-$24.23M
derived: sum of 3 quarters · filed 2021-03-17
-$33.17M
10-K · filed 2021-03-17
2019-09-30-$7.85M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16
-$14.66M
derived: sum of 2 quarters · filed 2020-11-16
-$23.60M
10-Q · filed 2020-11-16
-$32.00M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30-$6.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
-$15.75M
10-Q · filed 2020-08-11
-$24.15M
derived: sum of 3 quarters · filed 2020-08-11
-$28.29M
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31-$8.94M
10-Q · filed 2020-05-14
-$17.34M
derived: sum of 2 quarters · filed 2020-05-14
-$21.49M
derived: sum of 3 quarters · filed 2020-05-14
-$25.03M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31-$8.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11
-$12.54M
derived: sum of 2 quarters · filed 2020-03-11
-$16.08M
derived: sum of 3 quarters · filed 2020-03-11
-$18.51M
10-K · filed 2020-03-11
2018-09-30-$4.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-29
-$7.68M
derived: sum of 2 quarters · filed 2019-11-29
-$10.11M
10-Q · filed 2019-11-29
-$11.61M
derived: sum of 4 quarters · filed 2019-11-29
2018-06-30-$3.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-29
-$5.97M
10-Q · filed 2019-11-29
-$7.47M
derived: sum of 3 quarters · filed 2019-11-29
2018-03-31-$2.42M
10-Q · filed 2019-05-14
-$3.93M
derived: sum of 2 quarters · filed 2019-05-14
2017-12-31-$1.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
-$5.52M
10-K · filed 2019-03-15
2017-09-30-$4.02M
10-Q · filed 2018-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
NEXGEL, INC. (NXGL)United States$0.002B
Tenon Medical, Inc. (TNON)United States$0.002B
Profusa, Inc. (PFSA)United States$0.002B
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B